Amgen Inc.
AMGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $10 | $9 | $8 | $9 |
| % Growth | 4.3% | 12.5% | -10.3% | – |
| Cost of Goods Sold | $3 | $3 | $3 | $3 |
| Gross Profit | $6 | $6 | $5 | $6 |
| % Margin | 67.8% | 67.2% | 63.6% | 65.7% |
| R&D Expenses | $2 | $2 | $1 | $2 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $1 | $0 |
| Operating Expenses | $4 | $4 | $4 | $4 |
| Operating Income | $3 | $3 | $1 | $2 |
| % Margin | 26.4% | 28.8% | 14.5% | 25.4% |
| Other Income/Exp. Net | $1 | -$1 | $1 | -$2 |
| Pre-Tax Income | $4 | $2 | $2 | $1 |
| Tax Expense | $1 | $0 | $0 | $0 |
| Net Income | $3 | $1 | $2 | $1 |
| % Margin | 33.7% | 15.6% | 21.2% | 6.9% |
| EPS | 5.98 | 2.66 | 3.22 | 1.17 |
| % Growth | 124.8% | -17.4% | 175.2% | – |
| EPS Diluted | 5.93 | 2.65 | 3.2 | 1.16 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $6 | $4 | $4 | $3 |
| % Margin | 61.9% | 39.5% | 50.1% | 32.2% |